Jessica Eaton
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (14)
Year:
2026
Year:
2026
This study aims to assess the safety and efficacy of performing posterior lobe pituitary biopsy in patients with pituitary stalk lesions compared with direct stalk biopsy. We performed a single-institution retrospective review of four patients who underwent endoscopic transsphenoidal surgery of the posterior pituitary lobe for a lesion of the pituitary stalk without clear diagnosis, despite noninvasive workup. Four patients with known pituitary stalk lesions who underwent posterior pituitary biopsy without tumor resection. The main outcomes were postprocedural endocrine function across all axes compared with preoperative function, postprocedural morbidities, and ability to obtain an accurate histologic diagnosis from biopsy. A total of 100% (4/4) patients were histologically diagnosed based on tissue from transsphenoidal biopsy of the posterior lobe. There was no worsening of preoperative endocrine function. One patient experienced a cerebrospinal fluid leak. There were no other postoperative complications. None of the patients experienced worsening of vision attributable to biopsy. Transsphenoidal posterior lobe biopsy has a low-risk profile and high diagnostic capacity in patients presenting with a lesion of the pituitary stalk of uncertain etiology.
Year:
2026
Year:
2026
Year:
2025
Prostate cancer is the second most commonly diagnosed cancer in men worldwide, particularly in men 65 years and older. It has a high proclivity for metastasis to the bones, lymph nodes, and liver. Contrary to breast or lung cancer, prostate cancer (PC) metastasis to brain parenchyma is exceedingly rare, accounting for fewer than 1% of all brain metastases. Histologic classifications of PC metastasis subtypes continue to be refined in the literature, and the role of surgical management of PC metastases to the brain is evolving. There is a relative paucity of data regarding treatment recommendations for aggressive PC subtypes such as amphicrine carcinoma, which has both adenocarcinoma and neuroendocrine differentiation. This case report represents a rare instance of an intraparenchymal amphicrine PC metastasis. A 77-year-old right-handed man presented to the emergency department with transient aphasia, initially concerning for stroke. MRI revealed a 2 cm enhancing mass of the left middle temporal gyrus, with high-grade glioma leading the differential diagnosis based on imaging characteristics. His past medical history was notable for prostate adenocarcinoma metastatic to bone, lymph nodes, and liver. He underwent an awake craniotomy for gross total resection and discharged two days later. Final pathology revealed an amphicrine PC brain metastasis. He was treated with adjuvant gamma knife radiation, then resumed systemic chemotherapy and ADT. At 3 months, his functional status remained stable, and MRI showed no recurrence. Prostate cancer very rarely metastasizes to brain parenchyma. However, in a patient with prostate cancer and known metastases to bones or visceral organs, the differential for a new brain mass should include prostate metastasis. In these cases, surgical intervention must be considered in conjunction with radiotherapy, with particular attention to high grade subtypes of PC.
Year:
2025
INTRODUCTION: Blister aneurysms (BAs) of the supraclinoid internal carotid artery (ICA) pose unique treatment challenges due to their broad neck, friable adventitial walls, complex angioarchitecture and heterogeneity. There is a paucity of data on long-term outcomes of microsurgical bypass with clipping or trapping, and endovascular flow diversion (FD). METHODS: Data on all BAs treated by either bypass with clip-trapping or FD between 2005-2024 was retrospectively reviewed. Outcomes and complications were assessed in the immediate post-operative, 3months and long-term (>12months) follow-up periods. RESULTS: 22 patients with BAs [mean age 45yrs(SD ±11), 59%(13/22) females] were treated with bypass (13) and FD (9). The mean follow-up was 14months. The choice between endovascular and microsurgical treatment was based on Hunt-Hess grade at presentation and surgeon’s preference. The average aneurysm size was 3.5mm(range 1-8.2mm). Thirty-one percent (4/13) of the bypass patients had failed prior treatment. Patients undergoing endovascular FD had higher proportion of poor-grade subarachnoid hemorrhage (Hunt-Hess 4 or more) on presentation [55% (5/9) vs. 23% (3/13)]. Intraprocedural rupture rate was 23% (3/13) for the microsurgical group, and 11% (1/9) for the FD group. The immediate and follow-up aneurysm occlusion rate was 92% (12/13) and 100% (9/9) for the microsurgery group; and 33% (3/9) and 80% (4/5) for the FD group, respectively. Bypass graft patency was 100% immediately post-operation and 92% (12/13) at last-known imaging. The microsurgery group had no rebleeding or hemorrhage, 15% (2/13) stroke, and 8% (1/13) mortality. The FD group had 22%(2/9) rebleeding, 22%(2/9) intracerebral hemorrhage, 11%(1/9) stroke, and 22%(2/9) mortality. CONCLUSIONS: Both bypass with clip/trapping and endovascular flow diversion are useful treatments for supraclinoid ICA blister aneurysms. Cerebrovascular centers must have the ability to provide both treatment options for patients.
Year:
2025
BACKGROUND AND OBJECTIVES: Silent corticotroph pituitary neuroendocrine tumors (PitNETs) constitute approximately 20% of nonfunctional PitNETs and exhibit positive immunostaining for adrenocorticotropic hormone (ACTH). These tumors have been characterized as exhibiting high recurrence rates and poor response to repeat intervention as compared with other subsets of nonfunctional PitNETs. As such, we aimed to evaluate a multi-institutional experience of silent corticotroph (ACTH+) PitNETs to characterize the presentation, radiographic characteristics, and their clinical outcomes. METHODS: An Institutional Review Board-approved retrospective study of patients undergoing resection of PitNET at the University of Washington and University of Southern California between 2011 and 2023 was performed. Patients with negative immunostaining for ACTH and patients with biochemically confirmed Cushing's disease were excluded. Clinical and radiographic presentation and surgical outcomes are reported. RESULTS: A total of 277 patients between the two institutions underwent surgical resection of PitNET with positive immunostaining for ACTH. A total of 91 patients with Cushing's disease were excluded from analysis. The final cohort of patients with silent corticotroph PitNETs was 186. The cohort consisted of 114 women (61.3%) and the average age of all patients was 52.3 ± 14.5 years. There was a substantial rate of extrasellar growth into the suprasellar region (63.7%), cavernous sinus (56.4%), and clival/sphenoid (12.3%) compartments. Gross total resection was achieved in 79.7% of cases. The recurrence/progression-free survival at mean follow-up time of 21.5 months was 85.9%. CONCLUSION: Silent corticotroph PitNETs have high rates of extrasellar growth, often limiting the ability to achieve gross total resection. Recurrence/progression is common, occurring in 13% to 17% of cases within two years, necessitating the need for close postoperative follow-up.
Year:
2025
Year:
2024
BACKGROUND Treatment of pediatric craniopharyngioma requires a multidisciplinary approach to counsel patients and families on the spectrum of treatment options, including biopsy, radiation, and/or resection. Gross-total resection can avoid radiation and its long-term comorbidities. In very young patients, this is of particular importance but is especially challenging because of anatomical considerations. OBSERVATIONS A 23-month-old boy was found to have a partially calcified and cystic sellar and suprasellar mass. A fully endoscopic endonasal transtuberculum and transsellar approach was performed for gross-total resection of a subdiaphragmatic adamantinomatous craniopharyngioma. Postoperatively, the patient was diagnosed with panhypopituitarism with diabetes insipidus, though without other hypothalamic dysfunction or new visual deficits. To date, there is no evidence of tumor recurrence. LESSONS In a high-volume center with an experienced multidisciplinary skull base team, endoscopic endonasal approaches to sellar and suprasellar pathology in children younger than 2 years can be safely performed. A smaller nasal cavity and lack of sinus aeration necessitate wide exposure via bone removal and complete opening of the sinuses to enable an adequate working corridor to perform not only tumor resection but also reconstruction. Safe gross-total resection can avoid, or at least delay, radiation and its long-term morbidity when performed in a developing child. https://thejns.org/doi/10.3171/CASE24209
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (7)
Luis Gonzalez-Cuyar
Associate Professor
University of Washington
Vicente Martinez
Associate Professor/Neurophysiologist
University of Washington
DO HYEONG Lim
University of Washington
Dominic Nistal
University of Washington
P.J. Cimino
Associate Professor
George Washington University
Nancy Temkin
Acting assistant professor to Professor
University of Washington
Randall Chesnut
Professor
University of Washington
Make your next move.
Prepare your application
Review drafts before you send them.